Patent · US Active

Method for regulating retinal endothelial cell viability

US10010516B2 · kind B2 · utility

0Cited by

0References

10Claims

0Family size

Assignee

University of Tennessee Research Foundation · US

Inventors

Charles Ryan Yates · Collierville, US
Jena Steinle Smith · Olive Branch, US
Duane D. Miller · Germantown, US
Jordan J. Toutounchian · Memphis, US

Key dates

Filing date	Feb 9, 2017
Grant date	Jul 3, 2018
Priority date	—
Expiry date	Feb 9, 2037

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K31/4453
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Here provided is a method for regulating retinal endothelial cell viability in a mammal by administering to the mammal a therapeutically effective amount of a quinic acid analog. The method may be applied to prevent, treat or cure pathological conditions of retinal endothelial cells associated with radiation retinopathy, diabetic retinopathy and chemotherapy for retinoblastoma.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.